Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
BYTE Acquisition Corp. - Class A Ordinary Shares
(NQ:
BYTS
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EST, Dec 21, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about BYTE Acquisition Corp. - Class A Ordinary Shares
Airship AI Makes Its Debut On The Nasdaq After Completing Merger With BYTE Acquisition Corp.
December 28, 2023
--News Direct--
Via
News Direct
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Airship AI Makes Its Debut On The Nasdaq After Completing Merger With BYTE Acquisition Corp.
December 27, 2023
Airship AI (NASDAQ: AISP), the Redmond, Washington artificial intelligence company helping U.S.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 21, 2023
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
Via
Benzinga
Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket
December 19, 2023
Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering. Motus GI Holdings shares dipped 46.5% to $1.15 in...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 19, 2023
It's time to dive into the biggest pre-market stock movers as we check out all of the most recent news for Tuesday morning!
Via
InvestorPlace
Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
December 18, 2023
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in...
Via
Benzinga
Exposures
Product Safety
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.